Association between IMDC outcome and fecal calprotectin concentration at IMDC onset and after treatment of IMDC (N=77)
| IMDC outcome | n (%) | FC concentration at IMDC onset | FC concentration after IMDC treatment | ||
| Mean±SD, μg/g | P value | Mean±SD, μg/g | P value | ||
| Clinical remission | 0.019 | 0.064 | |||
| Yes | 65 (84) | 406±38 | 136±9 | ||
| No | 12 (16) | 641±98 | 180±15 | ||
| Endoscopic remission | 0.006 | <0.001 | |||
| Yes | 46 (60) | 361±44 | 110±8 | ||
| No | 31 (40) | 563±59 | 184±13 | ||
| Histologic remission | 0.097 | 0.029 | |||
| Yes | 24 (31) | 352±60 | 114±11 | ||
| No | 53 (69) | 483±41 | 152±10 | ||
| Recurrent IMDC | 0.080 | 0.804 | |||
| Yes | 16 (21) | 317±62 | 136±17 | ||
| No | 61 (79) | 475±43 | 141±9 | ||
FC, fecal calprotectin; IMDC, immune-mediated diarrhea and colitis.